Key points are not available for this paper at this time.
Patients with C-NORSE have a spectrum of clinical-immunological features different from those with NMDARE. The C-NORSE score may be useful for discrimination between them. Some patients could respond to immunotherapy.
Iizuka et al. (Tue,) studied this question.